Skip to main content
. 2023 Jun 30;14:1219177. doi: 10.3389/fpsyg.2023.1219177

Table 1.

Characteristics of the study participants.

Characterization of the participants
N Percentage
Sex Male 104 61.2
Woman 66 38.2
Age 7 years old 47 27.6
8 years old 61 35.9
9 years old 62 36.5
Diagnosis ASD 57 33.5
ASD + Epilepsy 53 31.2
Epilepsy 60 35.3
Years of treatment 2 years 34 20.0
3 years 73 42.9
4 years 63 37.1
Grade of incapacity Less than 33% 52 29.1
Between 33 and 66% 74 40
More than 66% 44 30.9
Educational supports at school Hearing and Language Teacher 41 30.6
Teacher of Hearing and Language and Therapeutic Pedagogy 87 51.2
Hearing and Language Teacher, Therapeutic Pedagogy and Educator 42 24.7
Gestation weeks 30–35 52 30.6
35–40 87 51.2
More than 40 31 18.2
Apgar With risk 77 45.3
Intermediate 63 37.1
Normal 30 17.6
Intellectual disability No presence 123 72.4
Mind 47 27.6
Pharmacological therapy No presence 52 30.6
Valproate 41 24.1
Risperidone 19 11.2
Clonazepam 58 34.1